Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Allergan Acquires Topokine
Monday, April 25, 2016
Adds global rights to XAF5, potential first-in-class topical treatment for steatoblepharon, or undereye bags.

Targeting an ‘Undruggable’ Cancer Gene
Monday, April 25, 2016
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.

Plasticell Awarded the Queen’s Award for Enterprise in Innovation 2016
Monday, April 25, 2016
Plasticell is pleased to announce it has been awarded the 2016 Queen’s Award for Enterprise in Innovation.

Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Friday, April 22, 2016
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.

Improving Engineered T-Cell Cancer Treatment
Friday, April 22, 2016
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

Uncovering How Some Breast Cancers Resist Treatment
Friday, April 22, 2016
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study.

Stand Up To Cancer Supports Innovative Research Grants for 10 Early Career Scientists
Thursday, April 21, 2016
Stand Up To Cancer (SU2C) has announced that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research.

Characterizing Cancerous Genomic Variations
Wednesday, April 20, 2016
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.

RXi Pharmas Gene Therapy Gets Patent Boost
Wednesday, April 20, 2016
RXi Pharmaceuticals Corporation has announced that it has received a Notice of Allowance, from the United States Patent and Trademark Office (USPTO), for both the composition of matter and methods of use for its self-delivering RNAi (sd-rxRNA®) compounds targeting connective tissue growth factor (CTGF.)

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 4099
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!